Researcher.Life Logo

Glomerular Diseases : Impact Factor & More

eISSN: 2673-3633
JournalOpen Access
Recommended pre-submission checks
Powered by Paperpal by Editage

Glomerular Diseases Journal Specifications

Indexed in the following public directories

  • DOAJ DOAJ
Overview
Publisher Karger Publishers
Language English
Article Processing ChargesUSD 990 | EUR 850 | CHF 920
Publication Time24
Editorial Review ProcessBlind peer review
General Details
LanguageEnglish
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 24
Editorial Review Detail
Editorial TeamVisit website
Review ProcessBlind peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY-NC
OA statementVisit website
View less

Planning to publish in Glomerular Diseases ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Glomerular Diseases

Nudging nephrologists in cardiovascular risk assessment and management in glomerular diseases treated with immunosuppressants: an implementation study
  • 23 Mar 2026
  • Glomerular Diseases
Serum Phospholipase A2 Receptor Antibody is Associated with Thrombogenesis in Primary Membranous Nephropathy: A Systematic Review and Meta-analysis
  • 19 Mar 2026
  • Glomerular Diseases
Contactin-1 Associated Membranous Nephropathy after multiple mRNA 1273 COVID-19 Vaccinations: A Case Report
  • 9 Mar 2026
  • Glomerular Diseases
Sodium-glucose cotransporter 2 inhibitors in lupus nephritis and ANCA-associated vasculitis: unmet needs to be addressed
  • 3 Mar 2026
  • Glomerular Diseases
Prediabetes in Children and Adults with Glomerular Disease
  • 3 Mar 2026
  • Glomerular Diseases
Successful Treatment of Refractory Immune Complex-Mediated Membranoproliferative Glomerulonephritis with Pegcetacoplan: A Case Report
  • 27 Feb 2026
  • Glomerular Diseases
Nudging nephrologists in cardiovascular risk assessment and management in glomerular diseases treated with immunosuppressants: an implementation study
  • 23 Mar 2026
  • Glomerular Diseases
Serum Phospholipase A2 Receptor Antibody is Associated with Thrombogenesis in Primary Membranous Nephropathy: A Systematic Review and Meta-analysis
  • 19 Mar 2026
  • Glomerular Diseases
Contactin-1 Associated Membranous Nephropathy after multiple mRNA 1273 COVID-19 Vaccinations: A Case Report
  • 9 Mar 2026
  • Glomerular Diseases
Sodium-glucose cotransporter 2 inhibitors in lupus nephritis and ANCA-associated vasculitis: unmet needs to be addressed
  • 3 Mar 2026
  • Glomerular Diseases
Prediabetes in Children and Adults with Glomerular Disease
  • 3 Mar 2026
  • Glomerular Diseases
Successful Treatment of Refractory Immune Complex-Mediated Membranoproliferative Glomerulonephritis with Pegcetacoplan: A Case Report
  • 27 Feb 2026
  • Glomerular Diseases

FAQs on Glomerular Diseases